<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2015-05-22</actionDate>
    </latestAction>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <amendments />
    <relatedBills>
      <item>
        <latestTitle>21st Century Cures Act</latestTitle>
        <latestAction>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
          <actionDate>2015-07-13</actionDate>
        </latestAction>
        <number>6</number>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <type>HR</type>
        <congress>114</congress>
      </item>
      <item>
        <latestTitle>Improving Medical Device Innovation Act</latestTitle>
        <latestAction>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
          <actionDate>2016-03-17</actionDate>
        </latestAction>
        <number>2737</number>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <type>S</type>
        <congress>114</congress>
      </item>
    </relatedBills>
    <billNumber>2427</billNumber>
    <updateDate>2016-11-02T22:08:03Z</updateDate>
    <cboCostEstimates />
    <sponsors>
      <item>
        <fullName>Rep. Shimkus, John [R-IL-15]</fullName>
        <firstName>JOHN</firstName>
        <district>15</district>
        <lastName>SHIMKUS</lastName>
        <byRequestType />
        <identifiers>
          <lisID>1527</lisID>
          <gpoId>7939</gpoId>
          <bioguideId>S000364</bioguideId>
        </identifiers>
        <middleName>M.</middleName>
        <party>R</party>
        <state>IL</state>
        <bioguideId>S000364</bioguideId>
      </item>
    </sponsors>
    <notes />
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Advisory bodies</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Product safety and quality</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <cosponsors />
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. SHIMKUS:H.R. 2427.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.[Page H3389]</pre>]]></constitutionalAuthorityStatementText>
    <calendarNumbers />
    <committeeReports />
    <billType>HR</billType>
    <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.</title>
    <introducedDate>2015-05-19</introducedDate>
    <actions>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>1</billReferrals>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2015-05-22</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <links />
        <actionCode>H11100</actionCode>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <links />
        <actionCode>Intro-H</actionCode>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <links />
        <actionCode>1000</actionCode>
        <actionDate>2015-05-19</actionDate>
      </item>
    </actions>
    <congress>114</congress>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2015-05-19</actionDate>
          <text><![CDATA[<p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to provide an opportunity for a person whose premarket submission for a medical device is subject to review by a classification panel to provide recommendations on the expertise needed among the members of the panel.</p> <p>The FDA must consider these recommendations and ensure that panels include at least two members with expertise clinically relevant to the device and at least one member who is knowledgeable about the technology of the device.</p> The person whose device is under review may designate a representative (who may be accompanied by experts) to participate in panel meetings.]]></text>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2015-11-16T17:35:17Z</lastSummaryUpdateDate>
          <updateDate>2015-05-19T04:00:00Z</updateDate>
          <actionDesc>Introduced in House</actionDesc>
        </item>
      </billSummaries>
    </summaries>
    <laws />
    <createDate>2015-05-20T08:46:22Z</createDate>
    <titles>
      <item>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-05-19T14:05:45Z</date>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-05-22T15:10:27Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <chamber>House</chamber>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

